ROME, June 11 (Reuters) - The Italian government said on
Friday it was restricting the use of the AstraZeneca COVID-19
vaccine to people over the age of 60, after a teenager who had
taken the shot died from a blood clot.
Camilla Canepa died on Thursday aged 18 after being given
the vaccine on May 25, triggering a storm of controversy in
Italy over the Anglo-Swedish brand being given to adults of all
ages despite previously-raised medical concerns.
"AstraZeneca will only be used for people over 60," the
country's special COVID commissioner Francesco Figliuolo told
reporters at a news conference.
(Reporting By Gavin Jones, editing by Angelo Amante)
Astrazeneca (AZN)
